Vir Biotechnology, Inc. (VIR)

Vir Biotechnology Statistics

Total Valuation

VIR has a market cap or net worth of $1.01 billion. The enterprise value is $209.20 million.

Market Cap	1.01B
Enterprise Value	209.20M

Important Dates

The next estimated earnings date is Thursday, February 20, 2025, after market close.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

VIR has 137.72 million shares outstanding. The number of shares has increased by 1.44% in one year.

Current Share Class	137.72M
Shares Outstanding	137.72M
Shares Change (YoY)	+1.44%
Shares Change (QoQ)	+0.31%
Owned by Insiders (%)	5.09%
Owned by Institutions (%)	52.15%
Float	92.52M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	12.67
Forward PS	19.27
PB Ratio	0.81
P/TBV Ratio	0.84
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	2.66
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.94, with a Debt / Equity ratio of 0.09.

Current Ratio	8.94
Quick Ratio	7.85
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -36.58% and return on invested capital (ROIC) is -21.79%.

Return on Equity (ROE)	-36.58%
Return on Assets (ROA)	-19.41%
Return on Capital (ROIC)	-21.79%
Revenue Per Employee	$133,932
Profits Per Employee	-$908,593
Employee Count	587
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

Income Tax	-5.84M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -26.82% in the last 52 weeks. The beta is 0.49, so VIR's price volatility has been lower than the market average.

Beta (5Y)	0.49
52-Week Price Change	-26.82%
50-Day Moving Average	8.02
200-Day Moving Average	8.89
Relative Strength Index (RSI)	43.75
Average Volume (20 Days)	1,515,225

Short Selling Information

The latest short interest is 6.16 million, so 4.48% of the outstanding shares have been sold short.

Short Interest	6.16M
Short Previous Month	5.51M
Short % of Shares Out	4.48%
Short % of Float	6.66%
Short Ratio (days to cover)	4.15

Income Statement

In the last 12 months, VIR had revenue of $78.62 million and -$533.34 million in losses. Loss per share was -$3.93.

Revenue	78.62M
Gross Profit	-416.93M
Operating Income	-550.09M
Pretax Income	-492.27M
Net Income	-533.34M
EBITDA	-533.94M
EBIT	-550.09M
Loss Per Share	-$3.93

Balance Sheet

The company has $914.47 million in cash and $112.81 million in debt, giving a net cash position of $801.66 million or $5.82 per share.

Cash & Cash Equivalents	914.47M
Total Debt	112.81M
Net Cash	801.66M
Net Cash Per Share	$5.82
Equity (Book Value)	1.24B
Book Value Per Share	9.08
Working Capital	930.00M

Cash Flow

In the last 12 months, operating cash flow was -$466.64 million and capital expenditures -$6.43 million, giving a free cash flow of -$473.07 million.

Operating Cash Flow	-466.64M
Capital Expenditures	-6.43M
Free Cash Flow	-473.07M
FCF Per Share	-$3.44

Margins

Gross Margin	n/a
Operating Margin	-699.70%
Pretax Margin	-685.83%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

VIR does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.44%
Shareholder Yield	-1.44%
Earnings Yield	-52.76%
FCF Yield	-46.80%

Analyst Forecast

The average price target for VIR is $36.40, which is 395.91% higher than the current price. The consensus rating is "Buy".

Price Target	$36.40
Price Target Difference	395.91%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	42.66%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

VIR has an Altman Z-Score of 1.93 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.93
Piotroski F-Score	1